References

Ellansé

* Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomised, controlled clinical trial. Dermatol Surg. 2013;39 (3 Pt 1):457-63. Journal of Cosmetic Dermatology.

** Expected longevity in-vivo based on extrapolation of clinical data from –S (1 year) and –M (2 years) accepted PCL degradation behaviour.

Perfectha

*J Fares, A prospective study of evaluation of the results achieved with the application of PERFECTHA Subskin, a new gel of hyaluronic acid non animal origin for malar and mental enhancement

Sinclair Network

At Sinclair we strive to provide the highest standards of training and ongoing support, working in partnership with our physician customers to deliver patients unparalleled clinical results and industry leading safety standards.

Sinclair Pharma News

Industry News

Sinclair Pharma and Tamer Group KSA announce exciting new partnership in the Middle East

Sinclair Pharmaceuticals Ltds. is delighted to announce its latest partnership in the Middle East with Tamer Group KSA, as its exclusive distributor in Saudi Arabia. Tamer Group is a leading healthcare, beauty care, prestige products, fast-moving consumer goods, and logistics company serving communities throughout the Middle East. We believe this new prestigious partnership with Tamer Group will be servicing the needs within the aesthetics sector of Saudi Arabia with the highest standards and ethics.
Read more on